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Objective: Endovascular repair of abdominal aortic aneurysm (AAA) is complicated by the potential for stent graft
migration over time. Factors including the type of fixation, initial proximal fixation length, and dilation and elongation
of the infrarenal aortic neck may contribute to device migration. We sought to determine when device migration is a real
phenomenon with actual device movement that compromises aneurysm exclusion.
Methods: Computed tomographic (CT) scans and computer reconstructions of all patients undergoing endovascular AAA
repair with a passive fixation device at our institution from June 1996 toOctober 2004were retrospectively reviewed. The
distance from the distal renal artery to the proximal end of the stent graft at the time of initial deployment was determined
for each patient.Migration was defined as a distance increase greater than 5mm in the follow-up period; proximal fixation
length, aortic neck enlargement and elongation, and neck angle were then measured. Data were further analyzed with
respect to AAA growth, development of endoleak, AAA rupture, and the need for reintervention.
Results: A total of 308 patients with endovascular AAA repairs using a passive fixation device had complete postoperative
imaging data sets; 48 patients (15.6%) with stent graft migration of 5 mm or more were identified, and 25 (8.1%) of these
had a migration of 10 mm or more. Seventeen (35.4%) of 48 migration patients had a total loss of the proximal seal zone
(loss patients); their average migration distance was 17.7  12.0 mm, with a mean neck shortening of 13.6  14.2 mm,
and the average proximal fixation length loss was 14.0  7.6 mm. Those 31 patients with an intact proximal seal zone
(nonloss patients) showed an average migration of 9.4 3.7 mm, with a mean neck lengthening of 9.6 8.4 mm and an
average proximal fixation length change of 0.7  8.0 mm. Univariate analysis demonstrated significant differences
between the loss and nonloss patients in follow-up duration (65.9 20.4 months vs 45.9 26.4 months; P .01), neck
dilatation at the distal renal artery (4.6 4.5mm vs 1.8 1.9mm; P .026), stent graft migration distance (17.7 12.0
mm vs 9.4  3.7 mm; P  .001), change in aortic neck length (13.6  14.2 mm vs 9.6  8.4 mm; P < .0001), change
in proximal fixation length (14.0 7.6mm vs 0.7 8.0mm; P< .0001), change in AAA size (1.8 7.1mm vs3.6 9.7
mm; P .033), and use of a stiff body stent graft (47.1% vs 19.4%; P .043). However, only change in aortic neck length
was statistically significant on multivariate analysis (odds ratio, 0.75; 95% confidence interval, 0.591-0.961; P  .022).
There were no differences between the loss and nonloss patients in time to migration discovery, initial AAA size, initial
aortic neck diameter or length, initial device oversizing, initial neck angle, neck angle increase, type II endoleak, or AAA
rupture. Eight of the 17 loss patients have been treated with proximal aortic cuffs; the remainder have refused
reintervention, died of unrelated causes, or elected to have open repair.
Conclusions: Postoperative elongation of the infrarenal aortic neck may create the radiographic perception of migration
without necessarily causing a loss of proximal stent graft fixation. Patients with a total loss of the proximal seal zone
actually have infrarenal aortic neck shortening, with a degree of neck dilatation beyond initial device oversizing that may
compromise proximal fixation length. Conversely, those with an intact proximal seal zone demonstrate aortic neck
elongation equivalent to migration, with no loss of proximal fixation length; these patients have a benign natural history
without intervention. Thus, aortic neck dilatation beyond oversizing, aortic neck shortening, and loss of proximal
fixation length are more clinically relevant predictors of proximal stent graft failure than simple migration distance.
(J Vasc Surg 2006;44:1176-81.)Abdominal aortic aneurysm (AAA) continues to pose a
significant public health risk to the aging population. The
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1176patient population encountered with AAA is typically el-
derly with numerous comorbidities, including diabetes
mellitus, coronary artery disease, chronic obstructive pul-
monary disease, renal dysfunction, and peripheral vascular
disease. This demographic subset results in high-risk surgi-
cal patients, particularly for open repair. As an alternative,
the feasibility and safety of endovascular AAA repair have
been clearly established in trials with several now Food and
Drug Administration (FDA)-approved, commercially avail-
able devices. Although the endovascular approach affords
shorter hospital stays, less postoperative pain, and lower
perioperative morbidity and mortality as compared with
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is required. Of particular concern is the potential for stent
fracture, cloth tears, device migration or dislodgement,
endoleak development, loss of stent graft fixation, loss of
aneurysm exclusion, aneurysm growth, and aneurysm rup-
ture.1-3
Postoperative surveillance is most frequently performed
with contrasted computed tomographic (CT) scanning aswell
as plain film interrogation, withmagnetic resonance imaging
reserved for patients whose renal function will not tolerate
iodinated contrast. The decision for reintervention is com-
plex and involves situations such as development of type I
or III endoleak, loss of proximal or distal stent graft fixa-
tion, device migration, continued aneurysm expansion with
a type II endoleak, or device fatigue with structural failure.
Although aneurysm growth and loss of aneurysm exclusion
constitute absolute indications for reintervention, the ques-
tion arises about the clinical significance of stent graft
migration without aneurysm reperfusion.
A significant subset of patients is noted to undergo
aneurysm regression, sometimes complete, after stent graft
repair; however, some of these same patients seem to
develop device migration on their postoperative imaging
(Fig 1). The aneurysm is gone, but the device seems to be
moving caudally. Other patients have less dramatic aneu-
rysm regression, but their devices likewise seem to be
migrating. Therefore, the question of reintervention
emerges: do these patients require proximal cuff extension
of the stent graft? Because the goal of AAA repair is to
prevent rupture and death and the likelihood of rupture
correlates with aneurysm size, it would seem that the an-
swer is no. However, how do we reconcile stent graft
migration with aneurysm shrinkage? It would seem that
migration should cause loss of proximal fixation and, thus,
loss of aneurysm exclusion leading to growth and potential
Fig 1. Device migration with aneurysm regression (the intra-
aortic thrombus has been rendered transparent).rupture.Even in the open vascular literature, it has been recog-
nized that suturing a prosthetic graft in the infrarenal aorta
poses a risk of subsequent proximal aortic neck dilation and
proximal suture line pseudoaneurysm.4 The sewn-in graft
cannot migrate, yet the infrarenal aortic neck enlarges and
elongates, thus creating the appearance of caudal displace-
ment. If this same mechanism were present in endovascular
AAA repair, it could explain the appearance of distal stent
graft migration without a loss of aneurysm exclusion.
The objective of this study was to determine whether
stent graft migration always represents a real phenomenon
with actual loss of the proximal stent graft seal zone or
whether it is sometimes explained by simple aortic neck
elongation. The device used for this study is the AneuRx
passive fixation device (Medtronic AVE, Santa Rosa, Calif).
METHODS
A total of 308 patients undergoing endovascular AAA
repair by using the AneuRx device at our institution be-
tween June 1996 and October 2004 had fine-cut CT
imaging data reconstructed as a 3-dimensional model by
Medical Metrx Solutions (West Lebanon, NH). The pa-
tient population involved had AneuRx stent grafts im-
planted during phase I, II, and III clinical trials, as well as
after FDA approval of the device. We identified 48 (15.6%)
of 308 patients who had evidence of stent graft migration of
5 mm or more; 25 (8.1%) of the 308 patients experienced
migration of 10 mm or more. Patient imaging data sets
were analyzed by comparing their most recent CT scans
with their immediate postoperative CT scans. The 8 of 48
migration patients who required proximal aortic cuff place-
ment were analyzed according to the last CT scan before
reintervention. The time to initial discovery of migration
was noted for life-table analysis, and the total duration of
postoperative follow-up was measured. The device oversizing
percentagewas calculatedbyusing the neck diameter from the
preoperative CT scan (30/48 patients) or intraoperative in-
travascular ultrasonography measurement (18/48 patients).
The proximal seal zone was defined qualitatively as the
region of overlap between the stent graft main body and the
infrarenal aortic neck and was measured quantitatively as
the proximal fixation length. Total loss of the proximal seal
zone was defined as a proximal fixation length equal to
zero, and migration was determined to be the change in
centerline distance from the lowermost renal artery to the
top of the stent graft over time (Fig 2). All longitudinal
measurements in this study were made in the vessel center-
line. Only 2 of the 48 migration patients had total AAA
regression; in their cases, the infrarenal neck length was
measured from the distal renal artery to the first discernible
point where the aortic diameter increased by 10%. In Fig 2,
a  b  c, where a is the infrarenal aortic neck length, b is
distal renal artery to top of stent graft distance, and c is the
proximal fixation length. Patients with infrarenal neck an-
gulation had centerline measurements taken from the distal
renal artery to the first CT slice with a full-circumference
stent graft. Proximal fixation length was measured as the
difference between aortic neck length and the distance
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a  b). In the middle scenario (stent graft migration), if
migration is a true phenomenon representing actual down-
ward device displacement without aortic neck elongation
(ie, a is constant), the migration distance b should increase
by the same amount that the proximal fixation length
c decreases. Likewise, if the aortic neck were to shorten (ie,
a decreases), then the proximal fixation length c would
shorten by the same amount and threaten loss of the
proximal seal zone; this problem would be compounded if
b also increased (ie, migration occurred). In the far right
example (aortic neck elongation), the distance a increases
by the same amount as the distance b (renal to stent graft
length) without any loss of proximal fixation length (ie, c is
constant).
To determine which factors cause stent graft migration
with a loss of proximal seal zone, the cohort of 48migration
patients was divided into 2 groups for comparison:
17 patients with total loss of the proximal seal zone (loss
patients) and 31 patients with intact proximal seal zones
(nonloss patients). For both groups, the aortic neck diam-
eter was measured just below the lowermost renal artery;
the change over time of these neck diameters was also
determined. Infrarenal aortic neck length, a, distal renal to
stent graft distance, b, and proximal fixation length, c, were
also measured directly, as were their respective changes
over time. Change in a is aortic neck elongation, b is stent
graft migration, and c is loss of proximal fixation length.
Initial AAA size, change in size with respect to time, aortic
neck angle relative to the AAA, and any increase during
follow-up were determined. The initial stent graft deploy-
ment position below the renal arteries was also measured.
All patient imaging studies were reviewed for endoleak
development or resolution. All patients charts were re-
viewed for documentation of aneurysm growth, need for
reintervention, and aneurysm rupture. For purposes of
life-table analysis, time to discovery of migration was deter-
Fig 2. Measuring changes in the infrarenal aortic neck: a b c,
where a is the infrarenal aortic neck length, b is the lowest renal to
top of stent graft distance, and c is the proximal fixation length. a
is aortic neck elongation, b is stent graft migration, and c is loss
of proximal fixation length.mined for all patients, as was duration of follow-up. Directcomparison between the two patient subgroups was per-
formed for each of these variables.
To determine whether stent graft migration distance is
different from aortic neck elongation length, the two mea-
surements were compared within each patient subgroup.
Centerline proximal fixation length and its change over
time were measured, and the change was independently
compared with the migration distance within each patient
subgroup.
All length measurements were taken in the vessel cen-
terline of the three-dimensional Medical Metrx Solutions
reconstructions. The results of all continuous data mea-
surements are expressed as means SD. Univariate analysis
was performed for all variables listed previously. The Stu-
dent t test was used to analyze continuous data, and the
Pearson 2 analysis was performed for categorical variables.
A P value of .05 was determined to be statistically signif-
icant. Multivariate logistic regression analysis was per-
formed on all variables determined to be significant on
univariate analysis. Life-table analysis was performed to
demonstrate the probability of migration with time.
RESULTS
A total of 308 patients undergoing endovascular AAA
repair with the AneuRx device at Harbor-UCLA Medical
Center had complete postoperative imaging data sets avail-
able. Of these 308 patients, 48 (15.6%) were found to have
stent graft migration of 5 mm or more; 25 (8.1%) of these
308 patients had migrations 10 mm or more. Seventeen
(35.4%) of the 48 migration patients had complete loss of
the proximal seal zone (loss patients), whereas 31 (64.6%)
of the 48 had an intact proximal seal zone (nonloss pa-
tients).
Loss vs nonloss patients. Comparing patients who
did and did not have a total loss of the proximal seal zone
(Table), there were statistically significant differences in
follow-up duration, stent graft migration distance, change
in aortic neck length, change in AAA size, change in aortic
neck diameter, use of the stiff body AneuRx stent graft, and
change in proximal fixation length. There were no signifi-
cant differences in time to detection of migration, initial
aortic neck length, initial aortic neck diameter, initial post-
deployment proximal fixation length, initial AAA size, ini-
tial aortic neck angulation or its change over time, degree of
stent graft oversizing, stent graft main body diameter, rate
of type II or III endoleak, or rate of AAA rupture. The
initial stent graft deployment distance below the distal renal
artery approached, but did not reach, statistical significance
between the loss and nonloss patients. By definition, loss
patients developed type I endoleaks and required aortic cuff
placement, whereas nonloss patients did not.
Multivariate logistic regression analysis was then per-
formed on variables determined to be significant between
loss and nonloss patients on univariate analysis. Follow-up
duration, stent graft migration distance, change in aortic
neck length, change in proximal fixation length, change in
AAA size, change in aortic neck diameter, and use of a stiff
body stent graft were entered into the multivariate analysis.
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was the only variable with a significant association with the
loss of the proximal seal zone (odds ratio, 0.75; 95%
confidence interval, 0.591-0.961; P  .022).
Migration vs elongation and loss of proximal
fixation. Within the loss patient subgroup of 17 patients,
the stent graft migration distance was significantly different
from the change in aortic neck length (17.7 12.9 mm vs
13.6  14.2 mm; P  .0001). The migration distance
was not significantly different from the loss of proximal
fixation length (17.7  12.9 mm vs 14.0  7.6 mm; P 
.30). In this subgroup, significant infrarenal aortic neck
dilatation (4.6  4.5 mm) and shortening (13.6  14.2
mm) occurred and led to a loss of proximal fixation. Fur-
thermore, this degree of neck dilatation (19.8%) exceeds
initial oversizing (12.7%  7.9%) and allows for a free-
floating proximal main body. Of the 17 loss patients, only 5
had type I endoleaks with visible perigraft blood flow, and
the remaining 12 patients showed a main body loosely
sealed against intra-aortic thrombus with no perigraft flow.
By contrast, the nonloss patient subgroup of 31 pa-
tients demonstrated a migration distance that was nearly
identical to the increased aortic neck length (9.4 3.7 mm
vs 9.6  8.4 mm; P  .89). Migration was significantly
different from the loss of proximal fixation length (9.4 
3.7 mm vs 0.7  8.0 mm; P  .0001). As noted previ-
ously, if c is constant (as in this subgroup), then the change
in a is equivalent to a change in b; in other words, because
there is no change in proximal fixation length, migration is
equivalent to aortic neck elongation. This subgroup dem-
onstrated aortic neck dilatation (1.8  1.9 mm, an 8%
increase) that was below the degree of initial oversizing
Table. Comparison of AAA characteristics between loss an
Variable Los
Follow-up duration (mo) 65
Migration detected (mo) 23
Initial distance below distal renal (b) (mm) 7
Stent graft migration distance (b) (mm) 17
Initial aortic neck length (a) (mm) 21
 Aortic neck length (a) (mm) -13
Initial proximal fixation length (c) (mm) 14
 Proximal fixation length (c) (mm) -14
Initial AAA size (mm) 51
 AAA size (mm) 1
Initial aortic neck angle (°) 31
 Aortic neck angle (°) 9
Initial aortic neck diameter (mm) 23
 Aortic neck diameter (mm) 4
Stent graft oversizing 12.7
Stent graft main body diameter (mm) 26
Stiff body stent graft
Type I endoleak
Type II endoleak
Type III endoleak
Aortic cuff placement
AAA rupture
AAA, Abdominal aortic aneurysm.(14.6%  9.0%). Over a mean follow-up duration of 20months after discovery of their migration, none of these 31
patients developed a type I endoleak, required reinterven-
tion, or experienced AAA rupture. In fact, these patients
had a significant trend toward AAA regression.
Life-table analysis. Life-table analysis of all 308 pa-
tients at risk for stent graft migration is presented in Fig 3.
For the various time points, there were 223 patients at risk
at 12 months after implantation, 137 patients at 24months,
74 patients at 36months, 30 patients at 48months, 7 patients
at 60months, and 2 patients at 72months. The probability of
nloss patients
ents Nonloss patients P value
20.4 45.9  26.4 .006
10.3 25.6  16.5 .70
10.9 3.1  5.4 .054
12.0 9.4  3.7 .013
13.2 20.1  7.5 .35
14.2 9.6  8.4 .0001
7.6 17.0  7.5 .19
7.6 0.7  8.0 .0001
8.9 55.9  12.3 .20
7.1 -3.6  9.7 .033
18.3 35.2  17.4 .51
13.8 5.9  13.5 .34
3.0 22.4  3.1 .38
4.5 1.8  1.9 .026
7.9% 14.6%  9.0% .47
1.6 26.6  2.4 .65
6 .04
0 .001
6 .11
0 NS
0 .0001
0 NS
Fig 3. Life-table analysis of the probability of stent graft migra-
tion more than 5 mm. There were 223 patients at risk at 12
months, 137 patients at 24 months, 74 patients at 36 months, 30
patients at 48months, 7 patients at 60months, and 2 patients at 72
months.d no
s pati
.9 
.9 
.7 
.7 
.9 
.6 
.0 
.0 
.5 
.8 
.7 
.8 
.2 
.6 
% 
.9 
8
5
7
0
8
0migration was 3.6% at 12 months, 9.4% at 24 months, and
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corresponding to traditional follow-up time points at 1, 2,
and 3 years after surgery.
DISCUSSION
Stent graft proximal fixation in the endovascular repair
of AAA with a passive fixation device such as the AneuRx is
dependent on adequate overlap between native aortic neck
tissue and the metallic stent structure of the device. The
radial force generated by the expanded stent drives the stent
against the aortic wall and prevents slippage. This requires a
certain degree of oversizing to provide secure apposition
through a friction seal. Over time, the durability of this appo-
sition affords long-term aneurysm exclusion. Of course, this
overlap between stent and aorta is compromised by aortic
neck thrombus, plaque, insufficient neck length, and high
degrees of angulation.
Nonetheless, stent graft migration has been elucidated
as one of the potential complications of endovascular AAA
repair.5-7 The mechanisms and etiology of this migration
have been extensively studied, although there are fewer
data in the literature concerning the clinical significance of
this radiographic finding.
Zarins et al5 published prospective data looking at
migration in patients undergoing endovascular AAA repair
as part of the multicenter AneuRx clinical trial. In their
analysis, a detailed consideration of the potential causative
factors for migration was presented. Short proximal fixation
length and low initial deployment of the stent graft were
identified as risk factors for later migration. Aortic neck
length and diameter, aneurysm size, degree of oversizing,
use of proximal cuffs at initial implantation, postprocedure
endoleak, demographic factors, and comorbid conditions
were not shown to be predictive of stent graft migration.
Similarly, Cao et al6 published data on a series of patients
with AneuRx devices implanted to treat AAAs. An analysis of
variables potentially causing device migration was also re-
ported. They found that aortic neck dilatation and large
aneurysm size were predictors of later migration. Low
deployment position, neck angulation, length, diameter,
and presence of endoleak were not determined to be sig-
nificantly predictive.
At our own institution, patients have had the AneuRx
stent graft device implanted for endovascular AAA repair
during phase I, II, and III of the US multicenter trial, as
well as after FDA approval. In reviewing our cumulative
database, 308 patients with complete postoperative imag-
ing data sets were identified. We noted 48 of 308 patients
with device migrations of 5 mm or more, of which 25
patients demonstrated migration of 10mm ormore. In this
migration group, 17 (35.4%) of 48 experienced a total loss
of the proximal seal zone and were referred to as loss
patients. Proximal seal zone failure was determined radio-
graphically by the lack of complete apposition of the prox-
imal stent with the aortic neck or by the presence of
proximal perigraft blood flow. Thirty-one (64.6%) of 48
patients demonstrated intact proximal seal zones and were
referred to as nonloss patients. The following question thenarose: do the nonloss patients simply have intermediate
degrees of loss of proximal fixation length, or is there
another mechanism producing the appearance of migration
without any actual loss of proximal fixation length? The
latter notion was supported by the observation (Fig 1) that
a certain number of patients had total disappearance of their
AAA, yet the stent graft seemed to be migrating. In such
patients, in whom the aneurysm is gone, there would be no
indication to intervene with a proximal aortic cuff. How-
ever, in patient with intermediate degrees of AAA regres-
sion, the answer is not so simple. In other words, when is
stent graft migration a clinically significant event necessitat-
ing surgical reintervention?
From the open vascular literature, it is well known that
even after open AAA repair with a sutured aortic graft, the
infrarenal neck is likely to continue enlarging in both length
and diameter over time.4 This causes caudal displacement
of the proximal suture line and may predispose to the
development of proximal suture line pseudoaneurysm. Per-
haps a similar phenomenon may be occurring in stent graft
repair of AAA, particularly in patients with low initial
deployment of the stent graft, thus subjecting the neck to
further biomechanical deterioration.8
To determine which factors may render migration a
true and clinically significant event, we compared critical
aneurysm and clinical characteristics between loss and non-
loss patients. Patients with migration who lose their proxi-
mal seal zone (loss patients) are those who have the longest
follow-up, a low initial stent graft deployment, subsequent
aortic neck dilatation and shortening, and ultimately loss of
all proximal fixation length. It is possible that low initial
deployment allows deterioration of the remaining uncov-
ered neck with dilatation and effective shortening. In loss
patients, the degree of aortic neck dilatation was found to
be significantly greater than the initial device oversizing,
thus allowing for a free-floating main body of the stent graft.
Time to migration detection, initial aortic neck length, initial
proximal fixation length, initial AAA size, initial aortic neck
angle and its change, initial aortic neck diameter, degree of
stent graft oversizing, rate of type II and III endoleaks, and
stent graft main body diameter were no different in loss vs
nonloss patients and do not help predict who will lose their
proximal seal zone.
The loss subgroup were also the earlier patients in our
experience, many of whom had the early stiff body AneuRx
device implanted. It is possible that this device was unable
to tolerate postoperative conformational changes in the
aneurysm sac, which in turn may have compromised its
ability to maintain a secure proximal seal. Of course, these
loss patients developed type I endoleaks, and all required
proximal aortic cuff placement. Eight patients received
cuffs, and the remaining nine patients died of unrelated
causes, refused reoperation, or had elective open AAA
repair. No loss patient experienced AAA rupture.
By contrast, the nonloss subgroup of patients demon-
strated a lesser overall degree of migration, but with no loss
in proximal fixation length. To elucidate the other mecha-
nism that may be causing the appearance of migration
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compared with aortic neck elongation as well as with loss of
proximal fixation length. Figure 2 displays these two dis-
tinct phenomena. In the first aneurysm on the left, the stent
graft has been deployed a distance b below the distal renal
artery in a neck that is a in length. Thus, c becomes the
proximal fixation length, as the difference between a and b.
If stent graft migration is a true phenomenon with actual
slippage of the device downward within the aortic neck,
then the increase in b over time should equal the loss of c,
assuming no change in a (although in the loss subgroup of
patients, aortic neck length a actually decreases while mi-
gration distance b increases, thus resulting in the proximal
fixation length c going to 0). If, however, aortic neck
elongation indeed occurs (a increases), b may increase
(creating the appearance of migration) without any loss of
proximal fixation length c. In this circumstance, the in-
crease in b should equal the increase in a (aortic neck
length) without any significant change in c. This example is
precisely what we see in the nonloss subgroup of patients. If
stent graft migration has occurred, but without loss of
proximal fixation length, it can be explained only by aortic
neck elongation.
As for the question of whether complete AAA regres-
sion may explain aortic neck elongation, only 2 (4.2%) of
the 48 migration patients demonstrated total aneurysm
collapse; most patients had much more modest degrees of
shrinkage, and some aneurysms actually grew. If aneurysm
regression were the sole explanation for neck elongation,
we would expect that proximal fixation length would in-
crease by an amount equal to the elongation length. This
was not the case in either the loss or nonloss patient groups.
Clinically, none of the 31 nonloss patients experienced
type I endoleak, a need for aortic cuff placement, or AAA
rupture during the average of 20 months’ follow-up after
initial migration discovery. One patient later required en-
dovascular treatment for development of a large hypogas-
tric artery aneurysm, obviously unrelated to a discussion
about migration. In fact, these nonloss patients actually had
a significant trend toward AAA regression. Thus, patients
showing stent graft migration due to aortic neck elongation
without a loss of proximal fixation length have a benign
natural history that does not warrant aortic cuff placement.
However, continued close surveillance is indicated.
CONCLUSION
Stent graft migration without a loss of proximal fixation
length may simply represent infrarenal aortic neck elonga-tion. Migration becomes clinically significant when there is
a concurrent loss of proximal fixation length, which occurs
when the aortic neck shortens and dilates beyond the
degree of device oversizing; these patients require aortic
cuff placement. Migration patients without a loss of proxi-
mal fixation length have a benign natural history that does
not warrant reintervention. Therefore, we suggest that
increased infrarenal aortic neck diameter beyond oversiz-
ing, infrarenal aortic neck shortening, and loss of proximal
fixation length are more clinically relevant predictors of
proximal stent graft failure than simple migration distance
alone.
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